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One of the most widespread diseases in the world is Coronary Heart Disease (CHD). It is also one of the most 
preventable. This review explores the management of CHD through changes in dietary modifications, 
lifestyle, and the use of dietary supplements and botanicals. 
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INTRODUCTION 
Hyperlipidemia is concerned as the cause for coronary 
heart diseases [1] and atherosclerosis which results from 
slow but sure deposition of lipids in arteries is a chief 
cause of mortality worldwide. [2]Though varieties of 
synthetic drugs are used in the treatment, still the 
searches are on for better medicaments especially from 
the plant kingdom. Many medicinal plants have been 
studied in this context. [1] WHO has predicted that, by 
2030, cardiovascular diseases will affect approximately 
23.6 million people around the world [3]. It has been 
reported that hypercholesterolemia contributes to 45% 
of heart attacks in Western Europe and 35% of heart 
attacks in Central and Eastern Europe. [4] The risk of 
heart attack is three times higher in those with 
hypercholesterolemia, compared to those who have 
normal blood lipid profiles. The WHO delineated that 
unhealthy diets, such as those high in fat, salt, and free 
sugar and low in complex carbohydrates, fruits, and 
vegetables, direct to increased risk of cardiovascular 
diseases. [5] Recent modalities for lowering blood 
cholesterol levels involve behavior modification, regular 
exercise, weight management, dietary management, and 
drug therapy. [6] effective pharmacological agents that 
reduce cholesterol levels are available in market may be 
useful in treatment of high cholesterol but  they are so 
expensive and are known to have severe side effects. [7] 
Epidemiological studies have demonstrated a positive 
significant relationship between obesity, sex, smoking, 
hypertension and plasma cholesterol concentration with 
coronary artery diseases (CAD). [8] Diet is one of the 
most important factors underlying atherosclerosis. High-
cholesterol diets enhance atherosclerosis and vegetarian 
diets are known to slow down the process. [1] Loss of 
elasticity of the inner arterial wall plus thickening and 
hardening of arteries are among the hallmarks of 
atherosclerosis. This is a progressive condition which 
starts from childhood and its clinical manifestations face 
in middle and old age. Three principal biological 
processes are involved in Atherosclerosis is namely (i) 
aggregation of smooth muscle cells, macrophages and T 
lymphocytes, (ii) formation of connective matrix by 
smooth muscle cells and (iii) accumulation, in cells and 
in the connective tissue surrounding the cells of lipids 
which are basically in the form of cholesterol esters and 
free cholesterol. [9] New medical research evaluating the 
relationship between plaque formation in arthrosclerosis 
& high cholesterol food. This section will focus 
primarily on the use of therapeutic lifestyle changes and 
the current state of evidence for diet, botanicals, and 
nutritional supplements that are generally used for the 
prevention and treatment of coronary heart disease 
(CHD). 
Lipids 
Lipids are a heterogeneous group of substances that are 
distinguished by their low solubility in water and their 
high solubility in nonpolar (organic) solvents. They are 
essential as energy stores and respiratory substrates, as 
structural components of cells, as vitamins, as 
hormones, for the protection of internal organs, for heat 
conservation, for digestion, and for lactation. [10] 
The major lipids found in the blood stream are  
 Cholesterol,  
 Cholesterol ester, 
 Triglycerides  
 Phospholipids 
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Cholesterol  
Cholesterol is a high molecular weight sterol. 
Cholesterol is not a fat. (It is fat soluble.) Cholesterol is 
an important component of the cell membranes, 
including organelle membranes inside the cell. 
Cholesterol biosynthesis is a multistep process which 
takes place mainly in the liver and the intestine, and 
involves more than twenty enzyme-catalyzed reactions 
for converting acetate into cholesterol (Figure 1). The 
rate limiting reaction in cholesterol biosynthesis is 
catalyzed by 3-hydroxy-3- methylglutaryl-CoA 
(HMGCoA) reductase, and it is this enzymatic step 
which has been used as pharmacological target of statin 
treatments (see below). 
Cholesterol is used by the body as raw material for the 
healing process. This is the reason the injured areas in 
the arteries (as in atherosclerosis) have cholesterol along 
with several other components (such as calcium and 
collagen) in the ‗scar‘ tissue that is formed to heal the 
‗wound‘. Cholesterol move through the blood with 
transporters, so-called lipoproteins like LDL and HDL. 
To perform its many important functions in the body, 
cholesterol is transported from the liver to the cells, 
tissues, and glands on low density lipoprotein carriers 
(LDL‘s). Reverse cholesterol transport (from the cells 
and tissues to the liver) is via high density lipoprotein 
carriers (HDL‘s). [11] 
 
Low-Density Lipoprotein (LDL). This lipoprotein 
maintains a large amount of cholesterol. The protein 
layer allows the tissues to use this cholesterol, LDL 
receptors on these tissues that make this interaction 
possible. In the tissues such as those of the liver and the 
inner layer of the arterial wall, cholesterol is taken away 
from low-density lipoproteins. Free radicals in the body 
are very reactive and oxidative compounds that can 
oxidize low-density lipoprotein cholesterol and help  
atherosclerotic plaque to form in the arteries so LDL is 
considered as Bad cholesterol. [12] 
 
High-Density Lipoprotein (HDL). The liver also 
produces another type of lipoprotein, named high-
density lipoprotein. High-density lipoprotein collects the 
surplus cholesterol that cholesterol metabolizing cells 
cannot utilize. Lecithin-cholesterol acyltransferase 
(LCAT) is an enzyme that is responsible for 
transporting surplus cholesterol back to HDL molecules. 
Unused cholesterol from arteries, liver, and other tissues 
is absorbed by HDL cholesterol. There is evidence that 
even some oxidized LDL can be removed by the LCAT 
and HDL cholesterol. So HDL is considered as good 
cholesterol. [13] HDL circulates in the body and collects 
the cholesterol from tissues, it becomes mature and goes 
back to the liver. There, it is identified by its lipoprotein 
covering and is lodged in the liver‘s cholesterol pool. 
 
Acetyl-CoA 
                
Acetoacetyl-CoA 
 
HMG-CoA 
 
Mevalonate 
 
Farnesyl-PP 
 
Squalene 
 
Cholesterol 
Fig.1 Process of cholesterol synthesis 
 
Cholesterol Esters  
Cholesterol is transported throughout the body in the 
form of cholesterol esters. Excess cholesterol is also 
stored intracellulary as cholesterol esters. The enzyme 
cholesterol esterase controls the hydrolysis of these 
stored cholesterol esters yielding bioavailable 
cholesterol and fatty acids. Cholesterol esterase 
hydrolyzes longchain and unsaturated fatty acid esters at 
a greater rate than short chain saturated fatty acids. 
Cholesterol esterase also contributes to the 
incorporation of cholesterol into mixed micelles and 
aids in the transport of free cholesterol into the 
enterocyte.[14] 
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Triglycerides 
The fat in the food we eat is mostly in the form of 
triglycerides. Triglycerides are the main type of fat 
transported by our body. After a meal, your body 
digests the fats of food and repackages the fat as 
triglycerides, which are released into our bloodstream. 
The blood carries the triglycerides throughout our body 
to give energy or to be stored as fat. Our liver also 
produces triglycerides and changes some into 
cholesterol. Our liver can change any source of excess 
calories into triglycerides. [15] But when your body 
makes too many triglycerides, the result can contribute 
to hyperlipidemia, a clinical word that describes the 
presence of too much ―bad‖ fat in our bloodstream. [16] 
 
Phospholipids  
Phospholipids (PLs) are amphiphilic lipids found in all 
plant and animal cell membranes, arranged as lipid 
bilayers. The cell membranes are basically containing 
glycerol-phospholipids (GPLs), which consist of fatty 
acids (FAs) esterified to a glycerol backbone, a 
phosphate group and a hydrophilic residue (e.g. choline, 
resulting in phosphatidylcholine or lecithin). The 
backbone of a PL can also be the long chain amino-
alcohol sphingosin instead of glycerol. These PL are 
classified as sphingophospholipids, the most 
representative being sphingomyelin, found in high 
quantities in brain and neural tissue, consisting of 
sphingosin esterified to one FA and phosphocholine.  
Besides glycerol phospholipids (GPLs) and 
sphingomyelin (SPM), biological membranes are also 
made up of glycolipids and cholesterol, as well as of 
integral and peripheral membrane proteins..[17] PLs 
extracted from food products (e.g. soybeans, egg yolk, 
milk, or marine organisms like fish, roe or krill) are 
defined as ―dietary GPLs‖. They can be ingested either 
with normal diet or as supplements. In a normal diet, the 
daily intake of PC is approximately 2-8 grams. [18] 
 
Dyslipidemia 
Dyslipidemia refers to a disruption of lipid metabolism 
with exceeding serum levels of cholesterol (TC), 
triglyceride (TG), low-density lipoprotein-cholesterol 
(LDL-C), and/or lower level of high-density 
lipoprotein-cholesterol (HDL-C). Serum levels of lipids 
and lipoprotein lipids are among the most potent and 
best substantiated risk factors for atherosclerotic 
diseases, particularly coronary heart disease (CHD). [24]  
 
Figure 2. Lipoprotein metabolism
19]
 
Abbreviations: apoB48, apolipoprotein B48; apo A1, 
apolipoprotein A1;  apoB100, apolipoprotein B100; TG, 
Triglyceride; LRP, LDL receptor-like protein; ABCA1, 
ATP-binding cassette A1; SRA1, SRB1, CD36, 3 
members of the scavenger receptor family; CETP, 
cholesteryl ester transfer protein; VLDL, very low 
density lipoprotein; IDL, intermediate density 
lipoprotein; LDL, low density lipoprotein; and HDL, 
high density lipoprotein 
 
Blocking Absorption of Dietary Cholesterol 
Dietary cholesterol is obtained from foods derived from 
animal sources that are rich in fat content. A healthy 
adult only needs to ingest about 30% of the daily 
cholesterol requirement. Obtaining more than this 
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amount from dietary cholesterol can lead to increased 
cholesterol levels and serious health risks. Dietary 
cholesterol is absorbed within the lumen of the small 
intestine. Bile salts produced from cholesterol in the 
liver interact with phospholipids to produce a biliary 
micelle that is transported via bile into the lumen. 
Dietary cholesterol in the lumen is easily incorporated 
into these micelles and together with the already present 
biliary cholesterol can now be absorbed into the 
enterocytes that make up the walls of the lumen. The 
micelles enter the cell by a channel know as Niemann-
Pick C1 like 1 protein (NPC1L1). Once in the cells the 
cholesterol can either be pumped back out into the 
lumen or it can be esterified for transport within 
chylomicrons. Preventing the absorption of this dietary 
cholesterol has become a key area in cholesterol related 
research. Plant sterols and stanols have been shown to 
be effective inhibitors of cholesterol absorption. 
Ingested as part of a normal diet, plant sterols and 
stanols are very similar in structure to cholesterol. They 
actually have a stronger binding affinity than cholesterol 
to the biliary micelles that aid in absorption. Because of 
this the sterols and stanols can displace cholesterol from 
the micelles thus preventing its absorption.  
Recently, inhibitors that block the absorption of the 
biliary micelles into the enterocytes have also been used 
to block the uptake of dietary cholesterol. [25]  
 
Dietary Intervention  
Heart healthy diets should be considered one of the 
primary therapeutic lifestyle interventions for patients 
with any level of risk for CHD. Prevention always 
trumps treatment. [26],[27] LDL cholesterol level can be 
reduced by limiting consumption of saturated fats 
(chees, red meat and whole-fat dairy products), 
increasing physical exercise and weight reduction. 
Increased consumption of monounsaturated fats (olive 
oil, fish fats and nuts) has been shown to reduce the 
LDL cholesterol & increases HDL cholesterol thus 
lowering CAD risk.The quest for finding the new safe & 
effective drug for dyslipidemia is going to be a 
continueous process among the scientific 
fraternity.herbs have been used as food and medicine 
for centuries.researchers showed intresthas focused on 
various herbs that possess antihyperlipidemic activity 
that may be useful adjuncts in helping reduce the risk of 
cardiovascular disease.A herbal diet with exercise is an 
effective prescription for anyone with elevated risk of 
cardiovascular disease.In addition there are a few herbs 
available that provide some help for persons with 
hyperlipidemia or other cardiovascular diseases.[ 28] 
 
Some pharmacological and clinical studies reported 
on ayurvedic and other herbs are described below: 
1) Sphaeranthus indicus [29] 
Tanpe et al studied the antihyperlipidemic property of 
aqueous extract of Sphaeranthus indicus in rats) 
(3oomg/kg/day,i.p) against dexamethasone 
(10mg/kg/day,s.c)induced changes in lipid profile in rat. 
Treatment with dexamethasone for eight days showed 
marked increase in the level of serum TC,TG and 
LDL,VLDL level where as HDL remain unchanged. 
Treatment with S. indicus (Asteraceae) showed 
significant decrease in  serum TC,TG and LDL,VLDL 
& there was no significant changes in the level of HDL. 
Atherogenic index also reduced significantly after S. 
indicus treatment. 
 
2) Panax notoginseng[30] 
Maintenance of normal lipid levels has implicated the 
involvement of genes induced by liver X receptor alpha 
(LXR alpha) and Farnesoid X receptor (FXR).This 
study was designed to evaluate the hypolipidemic 
effects of n-butanol extract (NE3) of Panax notoginseng 
root on lipid homeostasis and investigate the possible 
mechanisms in animal experiments. In the 
transactivation assays,NE3 was identified as a dual 
FXR/LXR alpha agonist. Subsequently, Sprague-
Dawley male rats on a high –fat diet were treated orally 
with NE3 or vehicle alone.as expected,the concentration 
of serum TC,TG and LDL-C in rats treated with various 
concentrations of NE3 showed significant (Pless than 
0.01) and dose –dependent decrease, respectively, 
accompanied with a significant (Pless than 0.01) and 
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dose –dependent decrease in concentration of hepatic 
TC& TG. Express-level analysis indicated that both 
LXR alpha target genes including 
ABCA1,ABCG5,ABCG8and FXR target genes 
including ApoCII and SHP were significantly induced 
by NE  (Pless than 0.01). Interestingly LDLR mRNA 
level was significantly higher by NE3 (Pless than 0.01) 
accompanied with decreased expression levels of 
CYP7A1, ApoCIII and SREBPIc genes (Pless than 
0.01).Based on these results, it can be concluded that 
NE3 as a dual FXR/LXRalphaagonist largely prevented 
the accumulation of abnormal lipid in the 
hyperlipidemic rats. 
 
3) Panicum miliare [31] 
 Hypolipidemic  potential of samai ( Panicum miliare , 
Gramineae) was evaluated  on selected fifty 
cardiovascular patients by Radha R. et al. for a period of 
sixty days (25 control; 25 supplemented with samai). 
Lipid profiles were analyzed before and after 
supplementation period for both control and 
experimental groups. It was noted that all the lipid 
values with the exception of HDL-cholesterol had 
reduced after supplementation with Samai and the 
reductions were statistically significant at 1 percent 
level. There was a mild increase in the HDL cholesterol 
level, which was desirable.  
 
4) Murraya koenigii [32] 
The powdered leaf of curry Murraya koenigii , Rutaceae 
was experimented in normal and alloxan induced 
diabetic rats to explore its cholesterol,triglyceride,blood 
urea nitrogen and alanine transaminase level.the result 
indicated significant reduction in the serum cholesterol 
and serum triglyceride level in the treated group. 
 
5) Camellia sinensis [33] 
To evaluate the antihyperlipidemic effect of  Camellia 
sinensis (CS) leaves Theaceae was administered at a 
dose of 200 microg/Kg (p.o.)to Triton induced 
hyperlipidemic rats by saravana kumar et al . 
Fenofibrate was used as reference standard. CS shows a 
significant decrease in the levels of serum cholesterol, 
phospholipid, triglyceride, LDL,VLDL and significant 
increase in the level of serum HDL at the dose of 200 
microg/Kg (p.o.) against Triton induced hyperlipidemic 
rats. Aqueous extract fraction decreased serum level of 
total cholesterol by 69.72 percent and increased the 
serum HDL cholesterpol level by 24.11 perccent. The 
decrease in LDL cholesterol level by aqueous extract 
was 30 percent. 
 
6)  Straw Mushroom [34] 
A study was conducted by Darwin christdhas Henry et 
al to  investigate the effect of paddy straw Mushroom 
Volvariella volvacea at the rate of 2.5 and 5.0 percent 
dosage on cholesterol accumulation in  blood and liver 
of weaning male white Albino wistar rats was assessed. 
The serum total cholesterol level of rats fed with 5 
percent decreased when compared to control over a 
period of 30,60 and 90 days. The reduction of 
cholesterol was due to the decreased cholesterol content 
in LDL. There was no significant difference found in 
serum HDL concentration. It is suggested that 
prolonged exposure to V. volvacea administrations 
reduced lipid and lipoprotein concentration significantly 
in rats. 
 
7) Ginko [35] 
It has been found in one of the animal studies that 
Maidenhair tree, Ginko biloba Linn. Extract (EGB761) 
inhibits beta amyloid production by lowering the free 
cholesterol. 
 
8) Gardenia jasminoides [36] 
The pancreatic lipase inhibitors were isolated from from 
the fructus of Gardenia jasminoides (Rubiaceae) and 
their antihyperlipidemic activities were measured by 
Lee I. A. et al. The water extract of Gardenia fruits (GF) 
inhibited pancreatic lipase activity. Crocetin  and crocin 
were isolated from GI water extract as inhibitors of 
pancreatic lipase with an Ic50 value of 2.1 and 
2.6mg/ml (triolein as a substrate) Crocetin  and crocin 
significantly inhibited the increase of serum TG level in 
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corn oil feeding induced triglyceridemic mice,as well as 
that of serum triglyceride and total LDL cholesterol 
levels in triton WR-1339-induced hyperlipidemic mice. 
These compounds also showed hypolipidemic activity 
in hyperlipidemic mice induced by high cholesterol high 
fat or high carbohydrate diets for 5 weeks.The results 
suggesting that the hypolipidemic activity of GF and its 
components crosin may be due to the inhibition of 
pancreatic lipase and crosin and its metabolite.crocetin 
can improve hyperlipidemia.  
 
9) Roselle[37] 
The effect of administrating of dried calyx extracts of 
roselle at 500 and 1000 mg/kg together in continuous 
cholesterol feeding to hyperholesterolemic rats for 6 
weeks significantly decreased serum cholesterol level 
by 22 percent & 26 percent respectively serum 
triglycerides level by 33 percent &28 percent 
respectively, serum triglycerides level by 22 percent & 
32 percent respectively six-week treatment with 
250,500 &1000 mg/kg of the extracts significantly 
decreased thiobarbituric acid reactive substances 
(TBARs) formation while the formation of conjugated 
dienes during the oxidation of LDL induced by CuSO4 
was reduced. but not significantly different. These lines 
of evidence suggest that the aqueous extracts from the 
dried calyx Hibiscus sabdariffa L.( roselle ) possess 
both antioxidant effects against LDL oxidation and 
hypolipidemic effects in vivo. 
 
10) Bottle gourd [38] 
In one of the intresting studies on juice of Bottle gourd 
(Lagenaria siceraria, Cucurbitaceae) was obtained by 
crushing the the fresh fruits in the juicer and was 
subsequently dried in the oven at 40-50΄C. The parent 
dried juice extract was than fractionated by using the 
solvent according to polarity in ascending order. Each 
fraction was dried in oven at 40-50΄C. Thin layer 
chromatography (TLC) used active fraction obtained by 
column chromatography for further isolation. The 
solvent system developed on trial and error basis was n-
butanol : methanol: water(6:2:2). Four spots were 
obtained and were named as LSN-I, LSN-II, LSN-III & 
LSN-IV. Isolated spots were collected by using 
preparative TLC the isolated compounds were tested for 
antihyperlipidemic activity  & compounds LSN-I, LSN-
II, LSN-III  has shown significant results. The study 
exhibited that elevated level of blood cholesterol, 
triglycerides, LDL, were significantly reduced & 
decreased HDL was significantly increased by the 
administration of fraction of Lagenaria siceraria fruits 
juice. 
 
11) Bellis perennis [39] 
The methanolic extract and its saponin fraction 
(methanol-eluted fraction) of the flowers of Bellis 
perennis (Asteraceae) were found to suppress serum 
triglyceride elevation in olive oil –treated mice. From 
the saponin fraction, seven new triterpene saponins, 
perennisosides I(1), II (2), III (3), IV (4), V (5), VI (6) 
& VII (7), were isolated together with four known 
saponins, bellidioside A (8), asterbatanoside D (9), 
bernardioside B2 (10), and bellissaponin BS6 (11).The 
stereostructures of 1-7 were elucidated on the basis of 
chemical and spectroscopic evidence. Among these 
saponins, perennisosides I(1)and II(2) showed inhibitory 
effects on serum triglyceride elevation at doses of 25-50 
mg/kg, po. 
 
12) Terminalia arjuna [40] 
The study was carried out to investigate the 
antihyperlipidemic action of Terminalia arjuna in 
fructose rich-high fat diet (HFD) fed hamsters. Bark 
powder of Terminalia arjuna was extracted with 
petroleum ether (fraction-A), solvent ether (fraction-B) 
and alcohol (fraction-C) and fed orally at a dose of 250 
mg/kg to HFD fed hamsters. At the end of ten days 
experiment, blood was withdrawn from each hamster to 
evaluate total cholesterol (TC) serum cholesterol, 
triglyceride (TG), HDL, glucose (Glu), glycerol (Gly) 
and free fatty acids (FFA) in plasma by standard 
spectrophotometric methods. Feeding with fructose rich 
HFD produced marked dyslipidemia in hamsters as the 
level of TC, TG, HD-TC, Glu, Gly and FFA was found 
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increased by 300,106,30,54,87 and 30 percent 
respectively. Treatment with fractions to dyaslipidemic 
hamsters caused reversal in the level of plasma lipid and 
glucose. The efficacy of different fraction of Terminalia 
arjuna was found, fraction-C more than fraction –B 
more than fraction-A.  
 
13) Helicteres isora [41] 
The aqueous extract of the bark of Helicteres isora 
(sterculiaceae), at 100 and 200 mg/kg dose  for 21 days 
lowered serum and tissue cholesterol, 
phospholipids,free fatty acids and triglycerides in STZ 
diabetic rats. Administration of this bark extract of 
Helicteres isora in addition to that, significant (p less 
than 0.05) decrease in LDL whereas significant increase 
(p less than 0.05) HDL were observed in STZ diabetic 
rats, which were normalized after 21 days of bark 
extract treatment. The bark extract at a dose of 200 
mg/kg b.w. showed much significant hypolipidaemic 
effect than at dose of 100 mg/kg b.w. 
 
14) Petrocarpus marsupium [42] 
Petrocarpus marsupium (Fabaceae) is used by 
traditional medicine practitioner of India for its 
hypolipidemic & antihyperlipidemic action. The 
alcoholic extract of plant was used for assessing its 
activity in albino rats when compared to standard drugs. 
The activity was assessed by studying the lipid profile 
in serum of the control and drug treated animals. The 
results lend support to the  traditional use of Petrocarpus 
marsupium in the treatment of Hyperlipidemia. 
 
15) Karela [43] 
Effects of three Japanese cultivars (Koimdori, Powerful- 
Reishi and Hyakunari of bitter melon (Momordica 
charania linn.) and those of methanol fraction extract of 
CV, Koimidori on serum and liver triacyglycerides were 
studied in rats by senanayake and others. Feeding of 
diets containing either bitter melon or various fractions 
isolated by organic solvents caused no adverse effects 
on food intake or growth of rats. when the effect of 
three different varieties of bitter melon was 
compared,the cv. koimidori was found to be the most 
effective in lowering hepatic triglyceride levels as 
compared to the other two cultivars, suggesting a 
variety- dependent difference in their activity. 
Furthermore, the active component(s) responsible for 
the liver triglyceride lowering activity of cv. koimidori 
was assumed to be concentrated in the methanol 
fraction, but not in other fraction, but not in other 
fractions such as the n-hexane, the acetone or the 
residual fraction. The triglyceride lowerining activity 
was furthermore confirmed by the dose-dependent 
reduction of hepatic triglyceride, the lowest level in rats 
fed 3.0% supplementation was observed. In these 
experiments, the effects on serum lipids were marginal. 
The results of these studies clearly show that bitter 
melon, especially cv. Koimidori exhibits a potent liver 
triglyceride lowering activity. 
 
16) Curcuma longa [44] 
Dou X. and others studied the effect  of curcumin, an 
active component of the rhizome of Curcuma longa 
(Zinziberaceae) were examined on LDL-R expression 
and its molecular mechanism in HepG2 cells. curcumin   
increased LDL-R expression (mRNA and protein) and 
the resultant uptake of Dil-LDL in a dose and time 
dependent manner. Using a GFP receptor system in a 
tranfected HepG2 /SRE-GFP cell line curcumin was 
found to activate the sterol regulatory element of the 
LDL-R promoter. In HepG2/Insig2 cells, curcumin 
reversed the inhibition of LDL-R expression induced by 
Insig2           over expression. The data demonstrate that 
curcumin increases LDL-R protein expression and 
uptake activity via the SREBPs pathway. These findings 
suggested the hypocholesterolemic and 
antiatherosclerotic effect of curcumin. 
 
17) Soyabean [45] [46] 
Convincing evidence shows that soyabean (Glycine max 
Merrill) protein intake has beneficial effects on lipid 
changes, but it is unclear which components of soy 
protein are responsible. Researchers have conducted a 
meta analysis to identify and quantify the effect of soy 
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protein with isoflavones intact was associated with 
significant decrease in serum total cholesterol (by 0.22 
mmol/L,or 3.77%),LDL cholesterol (by 0.21 mmol/L,or 
5.25%) and triacylglycerol (by 0.10 mmol/L,or 7.27%) 
and significant increases in serum HDL-cholesterol (by 
0.04 mmol/L,or 3.03%).the reduction in total and LDL 
cholesterol were larger in man then in women. Initial 
total cholesterol concentration had a powerful effect on 
changes in total and HDL-cholesterol, especially in 
subjects with hypercholesterolaemia. Studies with 
intake>80mg showed better effects on the lipid profile. 
The strongest lowering effects of soy protein containing 
isoflavones on total cholesterol, LDL cholesterol and 
triacylglycerol occurred within the short initial period of 
intervention, whereas improvements in HDL—
cholesterol were only observed in HDL-cholesterol 
were only observed in studies of >12 week duration. 
Tables containing extracted soy isoflavones did not 
have a significant effect on total cholesterol reduction. 
Thus, Soy protein containing isoflavones significantly 
reduce serum total cholesterol, LDL-cholesterol and 
triacylglycerol and increased HDL cholesterol,but the 
changes are related to the level and duration of intake 
and  the sex and initial serum lipid concentrations of the 
subjects. One more study on a peptide which was  
isolated by HPLC from the pepsin hydrolysate of 11S-
globulin isolated from the defatted soy (Glycine species, 
leguminosae). Its molecular weight (755.2 Da) and 
amino –acid sequence (Ile-Ala-Val-Pro-Gly-Glu-Val-
Ala) were established. The hypocholesterolemic activity 
was determined by analysis of  bile-acid and the percent 
inhibition of 3- hydroxyl-3-methyglutaryl coenzyme A 
reductase in vitro. The lowering of the cholesterol 
content is explained by bile acids bound to hydrolysate 
peptides shielding them from reabsorption & 
stimulating the transformation of cholesterol in blood 
plasma.  
 
18) Cucurbita pepo.[47] 
Dietary plants and herbal preparations have been 
traditionally used as medicine in developing countries 
and obtained a resurgence of use in resurgence of use in 
the various countries. Research carried out in last few 
decades has validated several such claims of use of 
traditional medicinal medicine plants. Popularity of 
pumpkin in various systems of traditional medicine for 
several aliments with antihypercholesterolemic activity 
focused the investigators attention on this plant. 
Considerable evidence from several epidemiological 
studies concerning bioactivities leads have stimulated 
and clinical trials designed to test this pharmacological 
actions. 
 
Conclusion 
In ayurveda, lipids can be equated with Medodhatu. 
Therefore, any drugs that will be working against kapha 
dosha or Medodhatu might act as lipid lowering agents. 
Also, there is a description of group of drugs such as 
Medoghna (the one which decreases the Medodhatu), 
Lekhana (the one which helps in reducing the body 
mass), Kaphaghna gana(the one which acts against  
which might demonstrate the antilipidemic activity. The 
commonest them will be the contents of Triphala i.e. 
three myrobalans, viz. Amalki (Emblica officinalis 
Gaertn. Syn. Phyllanthus emblica Linn.), Haritaki( 
Terminalia chebula Retz.) and Bibhitaki (Terminalia 
bellerica Roxb.) and Trimada i.e. Vidang (Embelia 
ribes), Musta (cyperus rotundus Linn.), Chitrak 
(Plumbago zeylanica Linnn.) and many more herbs 
given in a dosage form of Medohar guggul pills with a 
base of Guggul. Thus, we need to focus on our rich 
heritage of Ayurvedic Medicine and should adopt the 
accepted Golden triangle approach (a research 
collaboration of Traditional Medicine of India i.e. 
Ayurveda with Modern Basic Sciences and Modern 
Medical Science, so that we can approach more real 
solution on this front of lipid lowering drugs. 
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